Effects of statin monotherapy versus statin + ezetimibe on non-calcified coronary plaque (NCCP) assessed by computed tomography angiography in patients with stable angina pectoris with and without metabolic syndrome

Trial Profile

Effects of statin monotherapy versus statin + ezetimibe on non-calcified coronary plaque (NCCP) assessed by computed tomography angiography in patients with stable angina pectoris with and without metabolic syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Oct 2015

At a glance

  • Drugs Ezetimibe (Primary) ; HMG-CoA reductase inhibitors
  • Indications Angina pectoris; Atherosclerosis; Metabolic syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Oct 2015 New trial record
    • 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top